Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Sponsor: Kang Stem Biotech Co., Ltd.
Summary
A multi-center, open, long-term follow-up study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results from the K0104 Extension Study
Official title: Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results From the K0104 Extension Study
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
102
Start Date
2022-03-27
Completion Date
2030-06-30
Last Updated
2021-01-29
Healthy Volunteers
No
Conditions
Interventions
Not applicable(observational study)
Not applicable(observational study)
Locations (1)
Dongguk University Medical Center
Ilsan, South Korea